Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy
View ORCID ProfileScott Wilkinson, View ORCID ProfileHuihui Ye, View ORCID ProfileFatima Karzai, View ORCID ProfileStephanie A. Harmon, View ORCID ProfileNicholas T. Terrigino, View ORCID ProfileDavid J. VanderWeele, View ORCID ProfileJohn R. Bright, View ORCID ProfileRayann Atway, View ORCID ProfileShana Y. Trostel, View ORCID ProfileNicole V. Carrabba, View ORCID ProfileNichelle C. Whitlock, View ORCID ProfileStephanie M. Walker, View ORCID ProfileRosina T. Lis, View ORCID ProfileHoussein A. Sater, View ORCID ProfileBrian J. Capaldo, View ORCID ProfileRavi A. Madan, View ORCID ProfileJames L. Gulley, Guinevere Chun, View ORCID ProfileMaria J. Merino, Peter A. Pinto, View ORCID ProfileDaniela C. Salles, Harsimar B. Kaur, View ORCID ProfileTamara L. Lotan, View ORCID ProfileDavid J. Venzon, View ORCID ProfilePeter L. Choyke, View ORCID ProfileBaris Turkbey, View ORCID ProfileWilliam L. Dahut, View ORCID ProfileAdam G. Sowalsky
doi: https://doi.org/10.1101/2020.09.29.20199711
Scott Wilkinson
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
Huihui Ye
2Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215
3Department of Pathology and Department of Urology, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA, 90095
Fatima Karzai
4Genitourinary Malignancies Branch, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
Stephanie A. Harmon
5Molecular Imaging Program, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
6Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, 8560 Progress Drive, Frederick, MD, 21701
Nicholas T. Terrigino
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
David J. VanderWeele
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
7Department of Medicine, Feinberg School of Medicine, 420 E. Superior Street, Chicago, IL, 60611
John R. Bright
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
Rayann Atway
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
Shana Y. Trostel
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
Nicole V. Carrabba
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
Nichelle C. Whitlock
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
Stephanie M. Walker
5Molecular Imaging Program, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
Rosina T. Lis
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
Houssein A. Sater
4Genitourinary Malignancies Branch, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
Brian J. Capaldo
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
Ravi A. Madan
4Genitourinary Malignancies Branch, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
James L. Gulley
4Genitourinary Malignancies Branch, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
Guinevere Chun
4Genitourinary Malignancies Branch, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
Maria J. Merino
8Laboratory of Pathology, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
Peter A. Pinto
9Urologic Oncology Branch, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
Daniela C. Salles
10Department of Pathology, Johns Hopkins School of Medicine, 1550 Orleans Street, Baltimore, MD, 21287
Harsimar B. Kaur
10Department of Pathology, Johns Hopkins School of Medicine, 1550 Orleans Street, Baltimore, MD, 21287
Tamara L. Lotan
10Department of Pathology, Johns Hopkins School of Medicine, 1550 Orleans Street, Baltimore, MD, 21287
David J. Venzon
11Biostatistics and Data Management Section, National Cancer Institute, NIH, 9609 Medical Center Drive, Rockville, MD 20850
Peter L. Choyke
5Molecular Imaging Program, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
Baris Turkbey
5Molecular Imaging Program, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
William L. Dahut
4Genitourinary Malignancies Branch, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892
Adam G. Sowalsky
1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, 37 Convent Drive, Bethesda, MD, 20892
Posted September 30, 2020.
Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy
Scott Wilkinson, Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David J. VanderWeele, John R. Bright, Rayann Atway, Shana Y. Trostel, Nicole V. Carrabba, Nichelle C. Whitlock, Stephanie M. Walker, Rosina T. Lis, Houssein A. Sater, Brian J. Capaldo, Ravi A. Madan, James L. Gulley, Guinevere Chun, Maria J. Merino, Peter A. Pinto, Daniela C. Salles, Harsimar B. Kaur, Tamara L. Lotan, David J. Venzon, Peter L. Choyke, Baris Turkbey, William L. Dahut, Adam G. Sowalsky
medRxiv 2020.09.29.20199711; doi: https://doi.org/10.1101/2020.09.29.20199711
Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy
Scott Wilkinson, Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David J. VanderWeele, John R. Bright, Rayann Atway, Shana Y. Trostel, Nicole V. Carrabba, Nichelle C. Whitlock, Stephanie M. Walker, Rosina T. Lis, Houssein A. Sater, Brian J. Capaldo, Ravi A. Madan, James L. Gulley, Guinevere Chun, Maria J. Merino, Peter A. Pinto, Daniela C. Salles, Harsimar B. Kaur, Tamara L. Lotan, David J. Venzon, Peter L. Choyke, Baris Turkbey, William L. Dahut, Adam G. Sowalsky
medRxiv 2020.09.29.20199711; doi: https://doi.org/10.1101/2020.09.29.20199711
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2944)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12750)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4586)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4359)
- Nursing (236)
- Nutrition (639)
- Oncology (2271)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)